{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:56:00Z","timestamp":1761555360999,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.cct.2020.106187","type":"journal-article","created":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T17:42:50Z","timestamp":1603042970000},"page":"106187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["An adaptive clinical trial design for cocaine use disorder: Extended-release amphetamine salts for early behavioral intervention non-responders"],"prefix":"10.1016","volume":"98","author":[{"given":"Derek","family":"Blevins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth M.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances R.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2018","series-title":"2018 Annual Surveillance Report of Drug-related Risks and Outcomes\u2014United States","author":"Hoots","key":"10.1016\/j.cct.2020.106187_bb0005"},{"key":"10.1016\/j.cct.2020.106187_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-clinpsy-032511-143152","article-title":"A \u201cSMART\u201d design for building individualized treatment sequences","volume":"8","author":"Lei","year":"2012","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.cct.2020.106187_bb0015","series-title":"A Sequential Multiple Assignment Randomized Trial for Cocaine Cessation and Relapse Prevention: Tailoring Treatment to the Individual","first-page":"109","volume":"65","author":"Schmitz","year":"2018"},{"author":"Penn State College of Health and Human Development: The Methodology Center","key":"10.1016\/j.cct.2020.106187_bb0020"},{"issue":"7","key":"10.1016\/j.cct.2020.106187_bb0025","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1176\/appi.ajp.2012.12040474","article-title":"A model of placebo response in antidepressant clinical trials","volume":"170","author":"Rutherford","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.cct.2020.106187_bb0030","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC: American Psychiatric Publishing, Inc."},{"year":"2013","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","key":"10.1016\/j.cct.2020.106187_bb0035"},{"issue":"2","key":"10.1016\/j.cct.2020.106187_bb0040","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1037\/1064-1297.16.2.132","article-title":"Computerized behavior therapy for opioid-dependent outpatients: a randomized controlled trial","volume":"16","author":"Bickel","year":"2008","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.cct.2020.106187_bb0045","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/archpsyc.62.10.1148","article-title":"Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study","volume":"62","author":"Petry","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.cct.2020.106187_bb0050","series-title":"Imaging Dopamine Transmission in Cocaine Dependence: Response to Treatment Linked to Neurochemistry","first-page":"634","volume":"168(6)","author":"Martinez","year":"2011"},{"issue":"Suppl. 20","key":"10.1016\/j.cct.2020.106187_bb0055","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.cct.2020.106187_bb0060","series-title":"Measuring Alcohol Consumption: Psychosocial and Biochemical Methods","first-page":"41","article-title":"Timeline follow-back: a technique for assessing self-reported alcohol consumption","author":"Sobell","year":"1992"},{"year":"1998","series-title":"Cocaine Selective Severity Assessment (CSSA) 1998","author":"Kampman","key":"10.1016\/j.cct.2020.106187_bb0065"},{"year":"1995","series-title":"In Search of a Universal Drug Craving Scale","author":"Somoza","key":"10.1016\/j.cct.2020.106187_bb0070"},{"key":"10.1016\/j.cct.2020.106187_bb0075","series-title":"Substance Abuse and Psychological Flexibility: The Development of a New Measure","first-page":"3","volume":"19(1)","author":"Luoma","year":"2011"},{"year":"1976","series-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","key":"10.1016\/j.cct.2020.106187_bb0080"},{"issue":"3","key":"10.1016\/j.cct.2020.106187_bb0085","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the addiction severity index","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.cct.2020.106187_bb0090","series-title":"Annual Meeting of the National Cooperative Vaccine Development Group for AIDS","article-title":"The Risk Assessment Battery (RAB): validity and reliability","author":"DS","year":"1993"},{"issue":"2","key":"10.1016\/j.cct.2020.106187_bb0095","first-page":"321","article-title":"Quality of life enjoyment and satisfaction questionnaire: a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacol. Bull."},{"issue":"1","key":"10.1016\/j.cct.2020.106187_bb0100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.addbeh.2005.04.012","article-title":"Drug Stroop performance: relationships with primary substance of use and treatment outcome in a drug-dependent outpatient sample","volume":"31","author":"Carpenter","year":"2006","journal-title":"Addict. Behav."},{"issue":"2","key":"10.1016\/j.cct.2020.106187_bb0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1901\/jeab.1999.71-121","article-title":"Delay or probability discounting in a model of impulsive behavior: effect of alcohol","volume":"71","author":"Richards","year":"1999","journal-title":"J. Exp. Anal. Behav."},{"year":"1977","series-title":"WAIS-III WMS-III Technical Manual","author":"Tulsky","key":"10.1016\/j.cct.2020.106187_bb0110"},{"issue":"4","key":"10.1016\/j.cct.2020.106187_bb0115","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1037\/h0059831","article-title":"A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigl-type card-sorting problem","volume":"38","author":"Grant","year":"1948","journal-title":"J. Exp. Psychol."},{"key":"10.1016\/j.cct.2020.106187_bb0120","series-title":"A Sketch of the Implicit Relational Assessment Procedure (IRAP) and the Relational Elaboration and Coherence (REC) Model","first-page":"527","volume":"60(3)","author":"Barnes-Holmes","year":"2010"},{"year":"2005","series-title":"Behavior Rating Inventory of Executive Function\u2014Adult Version","author":"Roth","key":"10.1016\/j.cct.2020.106187_bb0125"},{"key":"10.1016\/j.cct.2020.106187_bb0130","series-title":"Client Commitment Language During Motivational Interviewing Predicts drug Use Outcomes","first-page":"862","volume":"71(5)","author":"Amrhein","year":"2003"},{"issue":"1","key":"10.1016\/j.cct.2020.106187_bb0135","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1037\/0022-006X.71.1.118","article-title":"Coping skills and treatment outcomes in cognitive-behavioral and interactional group therapy for alcoholism","volume":"71","author":"Litt","year":"2003","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.cct.2020.106187_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.drugalcdep.2014.01.012","article-title":"Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes","volume":"137","author":"Carroll","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.cct.2020.106187_bb0145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archpsyc.1989.01810020019004","article-title":"Desipramine facilitation of initial cocaine abstinence","volume":"46","author":"Gawin","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.cct.2020.106187_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0376-8716(00)00137-X","article-title":"Results of a baseline urine test predict levels of cocaine use during treatment","volume":"62","author":"Ehrman","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2020.106187_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107700","article-title":"Extended release mixed amphetamine salts and topiramate for cocaine dependence: a randomized clinical replication trial with frequent users","volume":"206","author":"Levin","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"6","key":"10.1016\/j.cct.2020.106187_bb0160","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/jamapsychiatry.2015.41","article-title":"Extended-release mixed amphetamine salts vs placebo for comorbid adult attention-deficit\/hyperactivity disorder and cocaine use disorder: a randomized clinical trial","volume":"72","author":"Levin","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.cct.2020.106187_bb0165","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1037\/a0029372","article-title":"Experimental design and primary data analysis methods for comparing adaptive interventions","volume":"17","author":"Nahum-Shani","year":"2012","journal-title":"Psychol. Methods"},{"issue":"2","key":"10.1016\/j.cct.2020.106187_bb0170","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.ajp.2007.06111851","article-title":"A meta-analytic review of psychosocial interventions for substance use disorders","volume":"165","author":"Dutra","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.cct.2020.106187_bb0175","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/archpsyc.1994.03950070060011","article-title":"Incentives improve outcome in outpatient behavioral treatment of cocaine dependence","volume":"51","author":"Higgins","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"issue":"10","key":"10.1016\/j.cct.2020.106187_bb0180","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/archpsyc.60.9.1043","article-title":"Community reinforcement therapy for cocaine-dependent outpatients","volume":"60","author":"Higgins","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.cct.2020.106187_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2003.12.006","article-title":"A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction","volume":"74","author":"Roozen","year":"2004","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.cct.2020.106187_bb0190","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0376-8716(03)00032-2","article-title":"Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients","volume":"70","author":"Kosten","year":"2003","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.cct.2020.106187_bb0195","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/00952990701313686","article-title":"Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial","volume":"33","author":"Moeller","year":"2007","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.cct.2020.106187_bb0200","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archpsyc.63.2.219","article-title":"Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population","volume":"63","author":"Poling","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.cct.2020.106187_bb0205","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.drugalcdep.2007.11.004","article-title":"Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform","volume":"94","author":"Schmitz","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2020.106187_bb0210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1741-7015-9-119","article-title":"Novel pharmacotherapeutic treatments for cocaine addiction","volume":"9","author":"Shorter","year":"2011","journal-title":"BMC Med."},{"key":"10.1016\/j.cct.2020.106187_bb0215","series-title":"Evaluation of the \u201cPipeline\u201d for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research","first-page":"533","volume":"68(3)","author":"Czoty","year":"2016"},{"key":"10.1016\/j.cct.2020.106187_bb0220","series-title":"Dextroamphetamine for Cocaine-dependence Treatment: A Double-blind Randomized Clinical Trial","first-page":"522","volume":"21(5)","author":"Grabowski","year":"2001"},{"issue":"10034","key":"10.1016\/j.cct.2020.106187_bb0225","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/S0140-6736(16)00205-1","article-title":"Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial","volume":"387","author":"Nuijten","year":"2016","journal-title":"Lancet"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714420302652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714420302652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:51:18Z","timestamp":1761555078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714420302652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":45,"alternative-id":["S1551714420302652"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2020.106187","relation":{},"ISSN":["1551-7144"],"issn-type":[{"type":"print","value":"1551-7144"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An adaptive clinical trial design for cocaine use disorder: Extended-release amphetamine salts for early behavioral intervention non-responders","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2020.106187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106187"}}